Uncle Sam Is Buying Into Quantum Computing Stocks. Should You?

The U.S. government invested just over $2 billion across nine quantum computing companies, with IBM, IonQ, D-Wave, and Rigetti among the beneficiaries and IBM receiving about half. The article argues that while the sector has major long-term potential, the pure plays remain highly unprofitable and richly valued, with IonQ, Rigetti, and D-Wave posting adjusted EBITDA losses of $96.8 million, $14.7 million, and $32.8 million in Q1 2026, respectively. IBM stands out as the only profitable name, with $15.9 billion in Q1 2026 revenue and $4 billion in adjusted EBITDA, and is portrayed as the least overvalued option.

Analysis

The government capital stamp of approval helps the sector’s narrative, but it does not change the underlying equity math: the pure-play names remain financing vehicles with technology optionality attached. In practice, the subsidy likely extends runway and compresses near-term bankruptcy risk, but it also legitimizes a higher cost of capital for the entire group by encouraging retail flows into assets that still have weak fundamental conversion from bookings to durable gross profit.

The second-order winner is IBM, not because quantum becomes a material earnings driver tomorrow, but because it can monetize credibility in adjacent enterprise deals, research partnerships, and public-sector procurement without needing a perfect standalone quantum outcome. That matters for competitive dynamics: cloud, semiconductor, and defense primes benefit more from “quantum adjacency” than from actual quantum revenue, and they will be the ones capturing follow-on budget dollars, integration work, and error-correction stack demand over the next 12-24 months.

The market is still pricing a binary breakthrough rather than a slow adoption curve. The real risk is that the next 6-9 months produce more headline contracts but no evidence of unit economics inflecting; if bookings remain lumpy and adjusted EBITDA losses stay wide, these stocks can de-rate even with improving sentiment. The contrarian read is that the current enthusiasm is underestimating dilution risk and overestimating the speed of commercialization, making the move in the pure plays vulnerable once the government headline fades.

For NVDA, the incremental angle is software and error-correction adjacency: even if quantum hardware remains years away, tooling around simulation, control, and hybrid workloads can support a small but strategic ecosystem wedge. That is less about immediate revenue and more about ecosystem lock-in, which is why the policy signal is modestly positive for platform names and only tactically positive for the hardware pure plays.

Key Decisions for Investors

• Long IBM / short IONQ pair trade for 3-6 months: captures the valuation gap between a profitable incumbent and a cash-burning pure play; best if the sector keeps rallying on policy headlines but fails to improve fundamentals.
• Avoid initiating fresh long exposure to RGTI/IONQ into post-news strength unless you are explicitly trading momentum; if held, use 25-30% trailing stops because any disappointment on bookings or dilution can re-rate these names quickly.
• Buy NVDA on pullbacks as a low-beta way to express quantum-adjacent ecosystem exposure over the next 12 months; treat it as a sentiment hedge rather than a direct quantum earnings callout.
• If seeking upside convexity, use call spreads on IONQ only after a pullback of 10-15% from event-driven highs, with a 6-9 month tenor; this avoids paying peak implied volatility for a story stock.
• For fundamental portfolios, overweight IBM versus the quantum basket over a 12-month horizon: you get policy optionality, enterprise credibility, and positive cash generation while avoiding financing/dilution risk.